Owner Novartis AG

Inventors Bullock, Gillian Rosemary; Ganter, Sabina Maria; De Gasparo, Marc

Agent Davies Collison Cave

Pub. Number AU-B-2009220022

Parent 2006203077

Filing date 24 September 2009

Wipo publication date 15 October 2009

Acceptance publication date 3 November 2011

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4178 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/437 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees